Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.
Sign Up to like & getrecommendations! Published in 2017 at "Allergy and asthma proceedings"
DOI: 10.2500/aap.2017.38.4090
Abstract: BACKGROUND Recombinant human C1 esterase inhibitor (rhC1-INH) is approved for treatment of hereditary angioedema (HAE) in adolescents and adults. HAE attacks that involve the upper airway can be life threatening, and data on the administration… read more here.
Keywords: airway involvement; attacks upper; treatment; upper airway ... See more keywords